BIRC2 Expression Impairs Anti-Cancer Immunity and Immunotherapy Efficacy
Author(s) -
Debangshu Samanta,
Tina Huang,
Rima Shah,
Yongkang Yang,
Fan Pan,
Gregg L. Semenza
Publication year - 2020
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2020.108073
Subject(s) - cancer research , immune checkpoint , cancer immunotherapy , immune system , immunotherapy , cd8 , melanoma , cytotoxic t cell , immunology , chemokine , cxcl9 , antibody , t cell , biology , medicine , chemokine receptor , biochemistry , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom